Court holds Sun-Ranbaxy deal amid insider trading charges
This article was originally published in Scrip
Executive Summary
Insider trading allegations came back to hound the mega Sun-Ranbaxy deal after certain investors moved an Indian court seeking a probe into the issue by the markets regulator, Securities and Exchange Board of India, and local bourses.